Mei Zhang

Mei Zhang


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MZMei Zhang
Mei Zhang
LZLinjie Zheng
Linjie Zheng
BLBenyong Lou
Benyong Lou
YZYanjie Zhang
Yanjie Zhang
RSRongjian Sa
Rongjian Sa
LZLongtao Zhang
Longtao Zhang
Bioactive polysaccharides (e.g., fucoidan, β-glucans, and medicinal plant polysaccharides) contain functional groups that interact with drug molecules, and some also retain their own biological activities. Through reversible noncovalent interactions, they can associate with small-molecule drugs and form supramolecular nanocomplexes, defined here as nanoscale assemblies in which the polysaccharide is a main structural component and its association with the drug contributes to assembly or drug retention. Multicomponent composites and bulk local matrices are discussed separately as related or extended systems. The review covers hydrogen bonding, hydrophobic association, electrostatic complexation, π–π stacking, and the cooperation among these interactions, together with the effects of pH, ionic strength, concentration, and solvent composition. Nanoprecipitation/solvent exchange, polyelectrolyte complexation, direct aqueous self-assembly, and microfluidic-assisted assembly are compared with respect to nanostructure formation, process control, and reproducibility. Molecular, colloidal, solid-state, and computational evidence is examined together when interpreting structure–assembly–performance relationships. Reported advantages include improved drug dispersibility, colloidal stability, release control, bioavailability, cellular uptake, biodistribution, and safety. In some systems, the polysaccharide itself may also contribute to therapeutic effects in tumors, inflammatory diseases, and wound healing. Related local-matrix systems are considered separately. Further development of these nanocomplexes will require better quantitative analysis of assembly mechanisms, more consistent polysaccharide characterization, careful biocompatibility assessment, scalable preparation, and longer-term safety evaluation.

4 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MZMei Zhang
Mei Zhang
LZLinjie Zheng
Linjie Zheng
BLBenyong Lou
Benyong Lou
YZYanjie Zhang
Yanjie Zhang
RSRongjian Sa
Rongjian Sa
LZLongtao Zhang
Longtao Zhang
Bioactive polysaccharides such as fucoidan, β-glucans, and medicinal plant polysaccharides contain functional groups that can interact with drug molecules, and some of them also retain their own biological activities. Through reversible noncovalent interactions, these polysaccharides can associate with small-molecule drugs and form supramolecular nanocomplexes. This review discusses hydrogen bonding, hydrophobic association, electrostatic complexation, π–π stacking, and the cooperation among these interactions. The effects of pH, ionic strength, concentration, and solvent composition on assembly behavior are also considered. Nanoprecipitation/solvent exchange, polyelectrolyte complexation, direct aqueous self-assembly, and microfluidic-assisted assembly are compared in terms of nanostructure formation, process control, and reproducibility. Evidence from molecular, colloidal, solid-state, and computational characterization is considered together to clarify the relationship between structure, assembly, and performance. Reported benefits include improved drug dispersibility, colloidal stability, release control, bioavailability, cellular uptake, biodistribution, and safety. In some systems, the polysaccharide component may also contribute to therapeutic effects in tumors, inflammatory diseases, infected wounds, and local regenerative matrices. Quantitative mechanism studies, polysaccharide standardization, biocompatibility assessment, process scale-up, and long-term safety evaluation remain necessary for the further development of these drug delivery systems.